Assignee
ARBOR PHARMACEUTICALS LLC
US·16 granted patents·23 pending applications·32 citations·filing 2013–2025
Top patents by PatentIndex Score
39 records- 0195US11517563B2Liquid nimodipine compositionsARBOR PHARMACEUTICALS LLC·Filed 2022·Granted Dec 6, 2022·5 cites·5 claims
- 0295US11413277B2Non-aqueous liquid nimodipine compositionsARBOR PHARMACEUTICALS LLC·Filed 2021·Granted Aug 16, 2022·5 cites·8 claims
- 0391US11938111B2Pharmaceutical compositions of dimethyl fumarateARBOR PHARMACEUTICALS LLC·Filed 2021·Granted Mar 26, 2024·1 cites·7 claims
- 0490US11013703B2Sotalol compositions and uses of the sameARBOR PHARMACEUTICALS LLC·Filed 2019·Granted May 25, 2021·2 cites·19 claims
- 0590US10576055B2Pharmaceutical compositions of dimethyl fumarateARBOR PHARMACEUTICALS LLC·Filed 2018·Granted Mar 3, 2020·2 cites·16 claims
- 0690US10342787B1Non-aqueous liquid nimodipine compositionsARBOR PHARMACEUTICALS LLC·Filed 2018·Granted Jul 9, 2019·7 cites·20 claims
- 0789US11229621B2Pharmaceutical compositions of dimethyl fumarateARBOR PHARMACEUTICALS LLC·Filed 2020·Granted Jan 25, 2022·2 cites·7 claims
- 0889US10576070B2Non-aqueous liquid nimodipine compositionsARBOR PHARMACEUTICALS LLC·Filed 2019·Granted Mar 3, 2020·5 cites·24 claims
- 0988US12440468B2Pharmaceutical compositions of dimethyl fumarateARBOR PHARMACEUTICALS LLC·Filed 2024·Granted Oct 14, 2025·0 cites·12 claims
- 1088US12290495B2Sotalol compositions and uses of the sameARBOR PHARMACEUTICALS LLC·Filed 2023·Granted May 6, 2025·0 cites·15 claims
- 1187US11850222B2Sotalol compositions and uses of the sameARBOR PHARMACEUTICALS LLC·Filed 2020·Granted Dec 26, 2023·1 cites·17 claims
- 1282US10940117B2Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofARBOR PHARMACEUTICALS LLC·Filed 2020·Granted Mar 9, 2021·1 cites·12 claims
- 1380US2024240229A1Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effectsARBOR PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 1480US2025319048A1Sotalol compositions and uses of the sameARBOR PHARMACEUTICALS LLC·Filed 2025·Application pending·0 cites
- 1579US2022095621A1Topical Avermectin Formulations and Methods for Elimination and Prophylaxis of Susceptible and Treatment Resistant Strains of Head LiceARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1679US2022159961A1Topical Avermectin Formulations and Methods for Elimination and Prophylaxis of Susceptible and Treatment Resistant Strains of Head LiceARBOR PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 1779US2024024249A1Oral dosage forms having a high loading of a methyl hydrogen fumarate prodrugARBOR PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1878US10945984B2Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effectsARBOR PHARMACEUTICALS LLC·Filed 2013·Granted Mar 16, 2021·1 cites·12 claims
- 1978US2025114457A1Pharmaceutical compositions of fumaric acid estersARBOR PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 2077US2020087272A1Treatment of multiple sclerosis and psoriasis using prodrugs of methyl hydrogen fumarateARBOR PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 2176US2021179573A1Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen FumarateARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 2276US2022251031A1Crystalline Form of y-Aminobutyric Acid AnalogARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 2376US2018242584A1Topical Avermectin Formulations and Methods For Elimination and Prophylaxis of Susceptible and Treatment Resistant Strains of Head LiceARBOR PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 2474US2020147019A1Gaba analog prodrug sustained release oral dosage formsARBOR PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 2573US2019166844A1Topical Avermectin Formulations and Methods For Elimination and Prophylaxis of Susceptible and Treatment Resistant Strains of Head LiceARBOR PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 2672US11229207B2Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head liceARBOR PHARMACEUTICALS LLC·Filed 2020·Granted Jan 25, 2022·0 cites·10 claims
- 2771US2024197661A1Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofARBOR PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 2870US11135296B2Pharmaceutical compositions of fumaric acid estersARBOR PHARMACEUTICALS LLC·Filed 2018·Granted Oct 5, 2021·0 cites·7 claims
- 2970US2021145755A1Oral dosage forms of methyl hydrogen fumarate and prodrugs thereofARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 3070US2020323804A1Gaba analog prodrug sustained release oral dosage formsARBOR PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 3170US2020283376A1Crystalline Form of y-Aminobutyric Acid AnalogARBOR PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 3269US2019256481A1Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen FumarateARBOR PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 3369US2019256480A1Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen FumarateARBOR PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 3467US2019152900A1CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOGARBOR PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 3567US2017118985A1Topical Avermectin Formulations and Methods For Elimination and Prophylaxis of Susceptible and Treatment Resistant Strains of Head LiceARBOR PHARMACEUTICALS LLC·Filed 2017·Application pending·0 cites
- 3667US2022241420A1Pharmaceutical Compositions of Fumaric Acid EstersARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 3766US10385014B2Acyloxyalkyl carbamate prodrugs, methods of synthesis and useARBOR PHARMACEUTICALS LLC·Filed 2018·Granted Aug 20, 2019·0 cites·11 claims
- 3864US2019247345A1Gaba analog prodrug sustained release oral dosage formsARBOR PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 3961US2021228525A1Methods of Administering Monomethyl Fumarate and Prodrugs Thereof Having Reduced Side EffectsARBOR PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →